IL6 and major depressive disorder: Clinical studies report higher levels of circulating proinflammatory cytokines, such as interleukin-1β, interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α), in patients with major depressive disorder (MDD) [3–5].